The astounding cost of the new Alzheimer’s drug - a podcast by Ric Edelman

And why is the Food and Drug Administration asking for another review? Listen to Ric Edelman share the latest on this controversial new treatment.

Further episodes of Everyday Wealth

Further podcasts by Ric Edelman

Website of Ric Edelman